Specifically, across various cancer types, HuR expression exhibited a negative correlation with the distribution of antitumor immune cells, including activated CD4 + T cells, activated CD8 + T cells, and activated dendritic cells, among others. The gene discussed is ELAVL1; the disease is cancer.